Article
The Effect of Germline Pathogenic Variants in the Upgrade Rate to Breast Cancer Among Patients Diagnosed With Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ on Core Needle Biopsy.
Clinical breast cancer - 1 Sept 2026
Ijaz Komal, Alston Broden, Bevers Therese, Arun Banu, Weber Diane, Yi Min, Hunt Kelly, Whitman Gary, Middleton Lavinia P
Abstract excerpt
INTRODUCTION: Atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) are high-risk lesions that may be identified on biopsy performed for evaluation of radiologic abnormalities. Most women diagnosed with ALH and LCIS do not develop breast cancer. Treatment recommendations are ill-defined when these lesions are discovered in patients with germline pathogenic variants (PV) in breast cancer...
Read the complete abstract on PubMedTopics
- Humans
- Female
- Breast Neoplasms
- Biopsy, Large-Core Needle
- Germ-Line Mutation
